Dexlansoprazole Capsule, Delayed Release
Product Images NDC 46708-823

Each capsule contains 30 mg of dexlansoprazole as enteric coated pellets. The usual dosage is provided in the package insert. Store at room temperature between 15°C to 30°C (59°F to 86°F) as per USP Controlled Capsules guidelines. It is recommended not to use if the seal is broken or missing. The package is child-resistant. A medication guide should be dispensed to each patient by PHARNACH. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. 30 capsules in the pack. Rx only.*

Each capsule contains 60 mg of dexlansoprazole as enteric coated pellets. The usual dosage can be found in the package insert. Store at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F) according to USP Controlled Room Temperature guidelines. Do not accept if seal over the bottle opening is broken or missing. The package is child-resistant. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. The product is Dexlansoprazole Delayed-Release Capsules, with 30 capsules in a prescription. The pharmacist is advised to dispense the accompanying Medication Guide to each patient. The manufacturing license number is G/25/2315. Lot and expiry date of the product are indicated as 11/2025.*

This text provides information on plasma concentration (in ng/mL) of Dexlansoprazole at two different dosages: 30 mg and 60 mg. The graph displays the concentrations over a period of time.*